DK318985A - Fremgangsmaade til fremstilling af 5-aryl-1,6-naphthyridin-2(1h)-on-derivater samt mellemprodukter til brug ved fremgangsmaaden - Google Patents
Fremgangsmaade til fremstilling af 5-aryl-1,6-naphthyridin-2(1h)-on-derivater samt mellemprodukter til brug ved fremgangsmaaden Download PDFInfo
- Publication number
- DK318985A DK318985A DK318985A DK318985A DK318985A DK 318985 A DK318985 A DK 318985A DK 318985 A DK318985 A DK 318985A DK 318985 A DK318985 A DK 318985A DK 318985 A DK318985 A DK 318985A
- Authority
- DK
- Denmark
- Prior art keywords
- procedure
- naphthyridine
- intermediates
- aryl
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/630,810 US4560691A (en) | 1984-07-13 | 1984-07-13 | 5-(Phenyl)-1,6-naphthyridin-2(1H)-ones, their cardiotonic use and preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
DK318985D0 DK318985D0 (da) | 1985-07-12 |
DK318985A true DK318985A (da) | 1986-01-14 |
Family
ID=24528649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK318985A DK318985A (da) | 1984-07-13 | 1985-07-12 | Fremgangsmaade til fremstilling af 5-aryl-1,6-naphthyridin-2(1h)-on-derivater samt mellemprodukter til brug ved fremgangsmaaden |
Country Status (19)
Country | Link |
---|---|
US (1) | US4560691A (fr) |
EP (1) | EP0168037B1 (fr) |
JP (1) | JPS6140286A (fr) |
KR (1) | KR870001089B1 (fr) |
AR (1) | AR242388A1 (fr) |
AT (1) | ATE50259T1 (fr) |
AU (1) | AU584103B2 (fr) |
DE (1) | DE3575926D1 (fr) |
DK (1) | DK318985A (fr) |
ES (1) | ES8706151A1 (fr) |
FI (1) | FI852765L (fr) |
GR (1) | GR851677B (fr) |
IL (1) | IL75733A (fr) |
MX (1) | MX161361A (fr) |
NO (1) | NO852677L (fr) |
NZ (1) | NZ212647A (fr) |
PH (1) | PH21844A (fr) |
PT (1) | PT80809B (fr) |
ZA (1) | ZA855280B (fr) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4532247A (en) * | 1983-08-08 | 1985-07-30 | Sterling Drug Inc. | 5-(Hydroxyalkyl or alkanoyloxymethyl)-1,6-naphthyridin-2(1H)-one and cardiotonic use thereof |
US4567186A (en) * | 1985-01-14 | 1986-01-28 | Sterling Drug Inc. | 5-Heteryl-1,6-naphthyridin-2(1H)-ones, cardiotonic use thereof and intermediates therefor |
NZ214837A (en) * | 1985-01-28 | 1988-10-28 | Sterling Drug Inc | 5-substituted 1,6 naphthyridin-2(1h)-ones |
DE3840341A1 (de) * | 1988-11-30 | 1990-06-07 | Basf Ag | Verfahren zur herstellung von 1-nitroanthrachinon-2-carbonsaeure |
US7235551B2 (en) * | 2000-03-02 | 2007-06-26 | Smithkline Beecham Corporation | 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases |
NZ524806A (en) * | 2000-10-23 | 2006-03-31 | Smithkline Beecham Corp | Tri-substituted 8H-pyrido[2,3-d]pyrimidin-7-one compounds |
RU2004133811A (ru) * | 2002-04-19 | 2005-04-20 | Смитклайн Бичам Корпорейшн (US) | Новые соединения |
AU2004212957A1 (en) * | 2003-02-14 | 2004-09-02 | Smithkline Beecham Corporation | Novel compounds |
JP2008535822A (ja) * | 2005-03-25 | 2008-09-04 | グラクソ グループ リミテッド | 新規化合物 |
UY29440A1 (es) | 2005-03-25 | 2006-10-02 | Glaxo Group Ltd | Nuevos compuestos |
WO2006104917A2 (fr) * | 2005-03-25 | 2006-10-05 | Glaxo Group Limited | Procede de preparation de derives pyrido[2,3-d]pyrimidin-7-one et 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one |
PE20061193A1 (es) * | 2005-03-25 | 2006-12-02 | Glaxo Group Ltd | DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2-[1H]-0NA COMO INHIBIDORES DE QUINASA p38 |
CN105218388B (zh) * | 2015-10-26 | 2017-07-11 | 西北农林科技大学 | β‑羰基烯胺类化合物及作为制备植物病原菌抗菌剂的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4412077A (en) * | 1982-03-15 | 1983-10-25 | Sterling Drug Inc. | Process for preparing 5-(lower-alkanoyl)-6-(lower-alkyl)-2(1H)-pyridinone |
US4415580A (en) * | 1982-08-02 | 1983-11-15 | Sterling Drug Inc. | Certain 2-(1H)-pyridinones cardiotonic compositions containing same and method of using same |
-
1984
- 1984-07-13 US US06/630,810 patent/US4560691A/en not_active Expired - Fee Related
-
1985
- 1985-07-03 NO NO852677A patent/NO852677L/no unknown
- 1985-07-04 NZ NZ212647A patent/NZ212647A/xx unknown
- 1985-07-05 IL IL75733A patent/IL75733A/xx unknown
- 1985-07-05 GR GR851677A patent/GR851677B/el unknown
- 1985-07-09 EP EP85108538A patent/EP0168037B1/fr not_active Expired - Lifetime
- 1985-07-09 MX MX8266A patent/MX161361A/es unknown
- 1985-07-09 AT AT85108538T patent/ATE50259T1/de not_active IP Right Cessation
- 1985-07-09 DE DE8585108538T patent/DE3575926D1/de not_active Expired - Fee Related
- 1985-07-10 JP JP15215885A patent/JPS6140286A/ja active Pending
- 1985-07-10 AU AU44747/85A patent/AU584103B2/en not_active Ceased
- 1985-07-11 AR AR85300954A patent/AR242388A1/es active
- 1985-07-11 PH PH32510A patent/PH21844A/en unknown
- 1985-07-12 ES ES545139A patent/ES8706151A1/es not_active Expired
- 1985-07-12 FI FI852765A patent/FI852765L/fi not_active Application Discontinuation
- 1985-07-12 ZA ZA855280A patent/ZA855280B/xx unknown
- 1985-07-12 DK DK318985A patent/DK318985A/da unknown
- 1985-07-12 PT PT80809A patent/PT80809B/pt unknown
- 1985-07-12 KR KR1019850004976A patent/KR870001089B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL75733A0 (en) | 1985-11-29 |
PH21844A (en) | 1988-03-17 |
FI852765A0 (fi) | 1985-07-12 |
AR242388A1 (es) | 1993-03-31 |
IL75733A (en) | 1988-07-31 |
DK318985D0 (da) | 1985-07-12 |
MX161361A (es) | 1990-09-18 |
NO852677L (no) | 1986-01-14 |
EP0168037B1 (fr) | 1990-02-07 |
ATE50259T1 (de) | 1990-02-15 |
ES8706151A1 (es) | 1987-06-01 |
JPS6140286A (ja) | 1986-02-26 |
EP0168037A3 (en) | 1986-03-26 |
KR870001089B1 (ko) | 1987-06-04 |
AU584103B2 (en) | 1989-05-18 |
FI852765L (fi) | 1986-01-14 |
GR851677B (fr) | 1985-11-26 |
AU4474785A (en) | 1986-01-16 |
PT80809B (en) | 1987-01-12 |
KR860001109A (ko) | 1986-02-22 |
EP0168037A2 (fr) | 1986-01-15 |
PT80809A (en) | 1985-08-01 |
NZ212647A (en) | 1988-07-28 |
US4560691A (en) | 1985-12-24 |
ES545139A0 (es) | 1987-06-01 |
DE3575926D1 (de) | 1990-03-15 |
ZA855280B (en) | 1986-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK160939C (da) | Analogifremgangsmaade til fremstilling af benzisothiazol- og benzisoxazolpiperazinderivater, samt mellemprodukter til anvendelse ved fremgangsmaaden | |
DK335686A (da) | Fremgangsmaade til fremstilling af 1-carba-3-cephem-4-carboxylsyrer ogderivater deraf samt mellemprodukter til brug ved fremgangsmaaden | |
DK167885D0 (da) | Nitromethylenderivater, mellemprodukter til fremstilling deraf, fremgangsmaade til deres fremstilling samt insecticider | |
DK425583A (da) | Fremgangsmaade til fremstilling af 4'-demethyl-epipodophyllotoxin-beta-d-ethylidenglycocid og acylderivater deraf samt mellemprodukt til brug ved fremgangsmaaden | |
NO863302D0 (no) | Fremgangsmaate ved fremstilling av 2-okso-1,3-dioksolaner. | |
DK214687A (da) | Thienopyrimidin-2,4-dionderivater samt mellempro- dukter ved fremstillingen deraf | |
DK318985D0 (da) | Fremgangsmaade til fremstilling af 5-aryl-1,6-naphthyridin-2(1h)-on-derivater samt mellemprodukter til brug ved fremgangsmaaden | |
DK698088A (da) | Piperidinylforbindelser, deres anvendelse samt mellemprodukter til brug ved fremstillingen af disse | |
DK567386D0 (da) | Fremgangsmaade til fremstilling af jerngenstande, saasom staebeforme og -kerner, samt koldhaerdende materiale til anvendelse ved denne | |
DK382785A (da) | Alfa-(o-chlorphenyl)-aminomethylen-beta-formylaminopropionitril, fremgangsmaade til fremstilling af dette samt anvendelse af dette til fremstilling af 2-methyl-4-amino-5-formylaminomethyl-pyrimidin | |
DK158310C (da) | Analogifremgangsmaade til fremstilling af substituerede 2,4-diamino-5-piperazinyl-pyrimidiner samt mellemprodukter til brug herved | |
DK165728C (da) | Fremgangsmaade til fremstilling af individuelt doserede indgivelsesportioner, samt ved fremgangsmaaden fremstillede indgivelsesportioner | |
ES516521A0 (es) | "metodo de preparar intermedios de ftalimidinas, ftalacinonas y similares". | |
DK467780A (da) | Fremgangsmaade til fremstilling af 24,24-difluor25-hydrochlecalciferol og mellemprodukter til brug ved fremgangsmaaden | |
DK326085D0 (da) | 4-amino-2-phenylquinoliner, deres fremstilling og anvendelse samt ved fremstillingen anvendelige mellemprodukter | |
DK177489A (da) | Cholestadienderivater som mellemprodukter til brug ved fremstillingen af homovitamin-d3-derivater | |
DK223783A (da) | Fremgangsmaade til fremstilling af dihydropyridiner samt mellemprodukter til anvendelse ved fremgangsmaaden | |
DK162988C (da) | Substituerede 3-(4-phenyl-1-piperazinyl)ethylquinazolin-2,4-(1h,3h)dioner, fremstilling deraf samt praeparater indeholdende samme | |
DK631386D0 (da) | 1-carbacephalosporin-antibiotika, fremgangsmaade til fremstilling deraf samt mellemprodukter til brug ved fremgangsmaaden | |
DK336379A (da) | Fremgangsmaade til fremstilling af benzodiazepinderivater samt mellemprodukter til anvendelse ved fremgangsmaaden | |
DK60485D0 (da) | Klon af crambe maritima l, fremgangsmaade til vegetativ formering deraf samt medier til anvendelse ved fremgangsmaaden | |
DK153485A (da) | Fremgangsmaade til fremstilling af aryl-substituerede pyrido(1,4)benzodiazepiner samt mellemprodukter hertil og deres fremstilling | |
DK602785A (da) | Fremgangsmaade til fremstilling af 3-substituerede n-pyridylindoler samt mellemprodukter til anvendelse ved fremgangsmaaden | |
DK312988A (da) | Fremgangsmaade til fremstilling af zidovudin samt mellemprodukter ved fremgangsmaaden | |
DK145685D0 (da) | Fremgangsmaade til fremstilling af 4-acetylimidazolderivater samt mellemprodukter til brug ved fremgangsmaaden |